Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 32, 2020 - Issue 2
165
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Physiological responses to cisplatin using a mouse hypersensitivity model

&
Pages 68-78 | Received 21 Nov 2019, Accepted 25 Feb 2020, Published online: 18 Mar 2020

References

  • Akuthota P, Xenakis JJ, Weller PF. 2011. Eosinophils: offenders or general bystanders in allergic airway disease and pulmonary immunity? J Innate Immun. 3(2):113–119.
  • Anderson SE, Franko J, Kashon ML, Anderson KL, Hubbs AF, Lukomska E, Meade BJ. 2013. Exposure to triclosan augments the allergic response to ovalbumin in a mouse model of asthma. Toxicol Sci. 132(1):96–106.
  • Basketter D A, Kimber I. 2011. Assessing the potency of respiratory allergens: Uncertainties and challenges. Regul Toxicol Pharm. 61(3):365–372.
  • Cetean S, Ciuleanu T, Leucuta DC, Cainap C, Constantin AM, Cazacu I, Cainap S, Gherman A, Oprean L, Hangan A, et al. 2015. Hypersensitivity reactions to platinum derivatives: findings of new predictive markers. J Buon. 20(6):1617–1623.
  • Cleare MJ, Hughes EG, Jacoby B, Pepys J. 1976. Immediate (type I) allergic responses to platinum compounds. Clin Exp Allergy. 6(2):183–195.
  • Czarnobilska E, Obtułowicz K, Wsołek K. 2007. Type IV of hypersensitivity and its subtypes. Przegl Lek. 64(7-8):506–508.
  • Dearman RJ, Basketter DA, Kimber I. 1998. Selective induction of type 2 cytokines following topical exposure of mice to platinum salts. Food Chem Toxicol. 36(3):199–207.
  • Dearman RJ, Basketter DA, Kimber I. 2013. Inter-relationships between different classes of chemical allergens. J Appl Toxicol. 33(7):558–565.
  • Foster WM, Walters DM, Longphre M, Macri K, Miller LM. 2001. Methodology for the measurement of mucociliary function in the mouse by scintigraphy. J Appl Physiol . 90(3):1111–1117.
  • Garssen J, Nijkamp FP, Van Der Vliet H, Van Loveren H. 1991. T-cell-mediated induction of airway hyperreactivity in mice. Am Rev Respir Dis. 144(4):931–938.
  • Hamelmann E, Schwarze J, Takeda K, Oshiba A, Larsen GL, Irvin CG, Gelfand EW. 1997. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med. 156(3):766–775.
  • Hartmann JT, Lipp HP. 2003. Toxicity of platinum compounds. Expert Opin Pharmacother. 4(6):889–901.
  • Hughes EG. 1980. Medical surveillance of platinum refinery workers. J Soc Occup Med. 30(1):27–30.
  • IPCS. 2012. Guidance for immunotoxicity risk assessment for chemicals. Harmonization project document No. 10. Geneva, Switzerland: World Health Organization.
  • Kosmidis C, Sapalidis K, Zarogoulidis P, Sardeli C, Koulouris C, Giannakidis D, Pavlidis E, Katsaounis A, Michalopoulos N, Mantalobas S. 2019. Inhaled cisplatin for NSCLC: facts and results. Int J Mol Sci. 20(8):1–12.
  • Ku HO, Jeong SH, Kang HG, Pyo HM, Cho JH, Son SW, Kim HR, Lee KJ, Ryu DY. 2008. Intracellular expression of cytokines and granzyme B in auricular lymph nodes draining skin exposed to irritants and sensitizers. Toxicology. 250(2–3):116–123.
  • Lehmann DM, Williams WC. 2018. Cross-reactivity between halogenated platinum salts in an immediate-type respiratory hypersensitivity model. Inhal Toxicol. 30(11-12):472–481.
  • Linnett PJ, Hughes EG. 1999. 20 years of medical surveillance on exposure to allergenic and non-allergenic platinum compounds: the importance of chemical speciation. Occup Environ Med. 56(3):191–196.
  • Makovec T. 2019. Cisplatin and beyond: molecular mechanisms of action and drug resistance development in cancer chemotherapy. Radiol Oncol. 53(2):148–158.
  • Makrilia N, Syrigou E, Kaklamanos I, Manolopoulos L, Saif MW. 2010. Hypersensitivity reactions associated with platinum antineoplastic agents: a systematic review. Met Based Drugs. 2010:1–11.
  • Matheson JM, Johnson VJ, Vallyathan V, Luster MI. 2005. Exposure and immunological determinants in a murine model for toluene diisocyanate (TDI) asthma. Toxicol Sci. 84(1):88–98.
  • Matheson JM, Lange RW, Lemus R, Karol MH, Luster MI. 2001. Importance of inflammatory and immune components in a mouse model of airway reactivity to toluene diisocyanate (TDI). Clin Exp Allergy. 31(7):1067–1076.
  • Murdoch RD, Pepys J. 1984a. Immunological responses to complex salts of platinum. I. Specific IgE antibody production in the rat. Clin Exp Immunol. 57(1):107–114.
  • Murdoch RD, Pepys J. 1984b. Immunological responses to complex salts of platinum. II. Enhanced IgE antibody responses to ovalbumin with concurrent administration of platinum salts in the rat. Clin Exp Immunol. 58(2):478–485.
  • Murdoch RD, Pepys J. 1985. Cross reactivity studies with platinum group metal salts in platinum-sensitised rats. Int Arch Allergy Immunol. 77(4):456–458.
  • Murdoch RD, Pepys J. 1986. Enhancement of antibody production by mercury and platinum group metal halide salts. Kinetics of total and ovalbumin-specific IgE synthesis. Int Arch Allergy Immunol. 80(4):405–411.
  • Murphy K, Janeway CA, Travers P, Walport M. 2012. Janeway’s immunobiology. 8th ed. New York: Garland Science.
  • Park SJ, Wiekowski MT, Lira SA, Mehrad B. 2006. Neutrophils regulate airway responses in a model of fungal allergic airways disease. J Immunol. 176(4):2538–2545.
  • Roberts AE. 1951. Platinosis; a five-year study of the effects of soluble platinum salts on employees in a platinum laboratory and refinery. AMA Arch Ind Hyg Occup Med. 4(6):549–559.
  • Rosales C. 2018. Neutrophil: a cell with many roles in inflammation or several cell types? Front Physiol. 9:113.
  • Santini D, Tonini G, Salerno A, Vincenzi B, Patti G, Battistoni F, Dicuonzo G, Labianca R. 2001. Idiosyncratic reaction after oxaliplatin infusion. Ann Oncol. 12(1):132–133.
  • Scheerens H, Buckley TL, Muis TL, Garssen J, Dormans J, Nijkamp FP, Van Loveren H. 1999. Long-term topical exposure to toluene diisocyanate in mice leads to antibody production and in vivo airway hyperresponsiveness three hours after intranasal challenge. Am J Respir Crit Care Med. 159(4):1074–1080.
  • Schuppe HC, Haas-Raida D, Kulig J, Bomer U, Gleichmann E, Kind P. 1992. T-cell-dependent popliteal lymph node reactions to platinum compounds in mice. Int Arch Allergy Immunol. 97(4):308–314.
  • Schuppe HC, Kulig J, Kuhn U, Lempertz U, Kind P, Knop J, Becker D. 1997. Immunostimulatory effects of platinum compounds: correlation between sensitizing properties in vivo and modulation of receptor-mediated endocytosis in vitro. Int Arch Allergy Immunol. 112(2):125–132.
  • Selgrade M, Boykin EH, Haykal-Coates N, Woolhiser MR, Wiescinski C, Andrews DL, Farraj AK, Doerfler DL, Gavett SH. 2006. Inconsistencies between cytokine profiles, antibody responses, and respiratory hyperresponsiveness following dermal exposure to isocyanates. Toxicol Sci. 94(1):108–117.
  • Shepherd GM. 2003. Hypersensitivity reactions to chemotherapeutic drugs. Clin Rev Allergy Immunol. 24(3):253–262.
  • Tarkowski M, Vanoirbeek JA, Vanhooren HM, De Vooght V, Mercier CM, Ceuppens J, Nemery B, Hoet PH. 2007. Immunological determinants of ventilatory changes induced in mice by dermal sensitization and respiratory challenge with toluene diisocyanate. Am J Physiol Lung Cell Mol Physiol. 292(1):L207–214.
  • Traidl C, Jugert F, Krieg T, Merk H, Hunzelmann N. 1999. Inhibition of allergic contact dermatitis to DNCB but not to oxazolone in interleukin-4-deficient mice. J Invest Dermatol. 112(4):476–482.
  • Ulrich P, Grenet O, Bluemel J, Vohr HW, Wiemann C, Grundler O, Suter W. 2001. Cytokine expression profiles during murine contact allergy: T helper 2 cytokines are expressed irrespective of the type of contact allergen. Arch Toxicol. 75(8):470–479.
  • Vanoirbeek JA, Tarkowski M, Ceuppens JL, Verbeken EK, Nemery B, Hoet PH. 2004. Respiratory response to toluene diisocyanate depends on prior frequency and concentration of dermal sensitization in mice. Toxicol Sci. 80(2):310–321.
  • Vanoirbeek JA, Tarkowski M, Vanhooren HM, De Vooght V, Nemery B, Hoet PH. 2006. Validation of a mouse model of chemical-induced asthma using trimellitic anhydride, a respiratory sensitizer, and dinitrochlorobenzene, a dermal sensitizer. J Allergy Clin Immunol. 117(5):1090–1097.
  • World Health Organization [WHO]. 2000. Platinum. Air quality guidelines for Europe. 2nd ed. Copenhagen: World Health Organization Regional Office for Europe; p. 166–169.
  • Williams WC, Copeland C, Boykin E, Quell SJ, Lehmann DM. 2014. Development and utilization of an ex vivo bromodeoxyuridine local lymph node assay protocol for assessing potential chemical sensitizers. J Appl Toxicol. 35:29–40.
  • Williams WC, Lehmann JR, Boykin E, Selgrade MK, Lehmann DM. 2015. Lung function changes in mice sensitized to ammonium hexachloroplatinate. Inhal Toxicol. 27(10):468–480.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.